Tag: Cancer

Genentech stops METLung Study

Genentech Provides Update On Phase III Study Of Onartuzumab in People With Specific Type of Lung Cancer SOUTH SAN FRANCISCO, CALIF. — 2014-03-02 Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that an independent…

OXiGENE, Inc. Announces $12 Million Public Offering

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2014 (GLOBE NEWSWIRE) — Press Release OXiGENE, Inc. (Nasdaq:OXGN) today announced that it has entered into definitive agreements with investors to purchase an aggregate of approximately $12 million of units, in a registered public…